- Home
- INLX vs ATRA Comparison
INLX vs ATRA Comparison
Compare INLX & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- ATRA
- Stock Information
- Founded
- INLX 1996
- ATRA 2012
- Country
- INLX United States
- ATRA United States
- Employees
- INLX N/A
- ATRA N/A
- Industry
- INLX EDP Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INLX Technology
- ATRA Health Care
- Exchange
- INLX Nasdaq
- ATRA Nasdaq
- Market Cap
- INLX 52.8M
- ATRA 48.5M
- IPO Year
- INLX N/A
- ATRA 2014
- Fundamental
- Price
- INLX $11.80
- ATRA $7.11
- Analyst Decision
- INLX
- ATRA Buy
- Analyst Count
- INLX 0
- ATRA 6
- Target Price
- INLX N/A
- ATRA $25.70
- AVG Volume (30 Days)
- INLX 6.4K
- ATRA 178.5K
- Earning Date
- INLX 03-27-2025
- ATRA 03-27-2025
- Dividend Yield
- INLX N/A
- ATRA N/A
- EPS Growth
- INLX N/A
- ATRA N/A
- EPS
- INLX N/A
- ATRA N/A
- Revenue
- INLX $17,930,991.00
- ATRA $100,439,000.00
- Revenue This Year
- INLX $8.35
- ATRA $1,281.31
- Revenue Next Year
- INLX $6.48
- ATRA N/A
- P/E Ratio
- INLX N/A
- ATRA N/A
- Revenue Growth
- INLX 7.17
- ATRA 2111.34
- 52 Week Low
- INLX $5.85
- ATRA $5.40
- 52 Week High
- INLX $16.50
- ATRA $23.45
- Technical
- Relative Strength Index (RSI)
- INLX 37.68
- ATRA 37.35
- Support Level
- INLX $11.15
- ATRA $8.05
- Resistance Level
- INLX $12.70
- ATRA $9.05
- Average True Range (ATR)
- INLX 0.52
- ATRA 0.85
- MACD
- INLX -0.12
- ATRA -0.06
- Stochastic Oscillator
- INLX 24.90
- ATRA 2.23
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).